Hematological Malignancies

Showing NaN - NaN of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematological Malignancies Trial in Worldwide (Teclistamab)

Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +80 more
Jan 27, 2023

Hematological Malignancies Trial in Worldwide (Pembrolizumab/vibostolimab coformuation)

Recruiting
  • Hematological Malignancies
  • Pembrolizumab/vibostolimab coformuation
  • Duarte, California
  • +64 more
Jan 27, 2023

Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

Active, not recruiting
  • Hematological Malignancies
  • Duarte, California
  • +26 more
Dec 7, 2022

Hematological Malignancies Trial in Worldwide (Talquetamab)

Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +82 more
Aug 11, 2022

Hematological Malignancies Trial in Worldwide (Talquetamab)

Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +14 more
Jul 14, 2022